Accreditation/
Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 1.5 Contact Hours.
Acknowledgment of Commercial Support
This activity is supported by educational grants from Celgene Corporation, Incyte Corporation, and PharmaEssentia USA.
Suite 100
Cranbury, NJ 08512
P: 1-609-378-3701
Copyright © 2019
Physicians’ Education Resource ®, LLC.
All rights reserved.
LIVE Virtual Tumor Board®: Diagnosis and Management of Polycythemia Vera and Myelofibrosis
February 21, 2019
8:00 PM EST
Upon registration you will receive an email containing the link to the Live Webcast
Registration
2 Ways to Register- Online: click here.
- Phone: Please call (888) 949-0045 or (609) 378-3701.
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free
Please note that attendance is on a first-come, first-served basis. Please arrive early to ensure your spot!
For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.
Meeting information is accurate at the time of posting.
PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.
